CENTRAL GARDEN AND PET CO-A (CENTA) Fundamental Analysis & Valuation

Name: CENTRAL GARDEN AND PET CO-A (CENTA) Fundamental Analysis Rating
Brand: CENTRAL GARDEN AND PET CO-A

NASDAQ:CENTA • US1535272058

32.49 USD

-0.37 (-1.13%)

At close: Mar 27, 2026

32.49 USD

0 (0%)

After Hours: 3/27/2026, 8:05:43 PM

This CENTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1. CENTA Profitability Analysis

1.1 Basic Checks

CENTA had positive earnings in the past year.
CENTA had a positive operating cash flow in the past year.
Each year in the past 5 years CENTA has been profitable.
Of the past 5 years CENTA 4 years had a positive operating cash flow.

1.2 Ratios

CENTA's Return On Assets of 4.27% is on the low side compared to the rest of the industry. CENTA is outperformed by 75.00% of its industry peers.
The Return On Equity of CENTA (9.88%) is worse than 66.67% of its industry peers.
With a Return On Invested Capital value of 6.30%, CENTA is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
CENTA had an Average Return On Invested Capital over the past 3 years of 6.05%. This is significantly below the industry average of 14.94%.
The 3 year average ROIC (6.05%) for CENTA is below the current ROIC(6.30%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	4.27%
ROE	9.88%
ROIC	6.3%

ROA(3y)3.75%

ROA(5y)4.15%

ROE(3y)8.63%

ROE(5y)9.94%

ROIC(3y)6.05%

ROIC(5y)6.55%

1.3 Margins

The Profit Margin of CENTA (5.04%) is worse than 75.00% of its industry peers.
CENTA's Profit Margin has improved in the last couple of years.
The Operating Margin of CENTA (8.21%) is worse than 75.00% of its industry peers.
In the last couple of years the Operating Margin of CENTA has grown nicely.
The Gross Margin of CENTA (32.29%) is worse than 66.67% of its industry peers.
In the last couple of years the Gross Margin of CENTA has grown nicely.

		Industry Rank	Sector Rank
OM	8.21%
PM (TTM)	5.04%
GM	32.29%

OM growth 3Y2.97%

OM growth 5Y2.97%

PM growth 3Y4.51%

PM growth 5Y3.05%

GM growth 3Y2.55%

GM growth 5Y1.64%

More info and screens

ROA ROE ROIC Operating and Profit Margin Show most profitable peers

2. CENTA Health Analysis

2.1 Basic Checks

CENTA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CENTA has been reduced compared to 1 year ago.
Compared to 5 years ago, CENTA has more shares outstanding
CENTA has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.52 indicates that CENTA is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.52, CENTA is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
CENTA has a debt to FCF ratio of 4.18. This is a neutral value as CENTA would need 4.18 years to pay back of all of its debts.
The Debt to FCF ratio of CENTA (4.18) is comparable to the rest of the industry.
CENTA has a Debt/Equity ratio of 0.76. This is a neutral value indicating CENTA is somewhat dependend on debt financing.
CENTA has a Debt to Equity ratio (0.76) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.76
Debt/FCF	4.18
Altman-Z	2.52

ROIC/WACC0.89

WACC7.07%

2.3 Liquidity

A Current Ratio of 3.42 indicates that CENTA has no problem at all paying its short term obligations.
CENTA has a better Current ratio (3.42) than 91.67% of its industry peers.
A Quick Ratio of 1.97 indicates that CENTA should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.97, CENTA belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.42
Quick Ratio	1.97

More info and screens

WACC Debt/Equity How to determine the health of a company Altman-Z score Show peers with great health

3. CENTA Growth Analysis

3.1 Past

The Earnings Per Share has grown by an nice 16.24% over the past year.
Measured over the past 5 years, CENTA shows a small growth in Earnings Per Share. The EPS has been growing by 3.68% on average per year.
Looking at the last year, CENTA shows a decrease in Revenue. The Revenue has decreased by -4.11% in the last year.
Measured over the past years, CENTA shows a small growth in Revenue. The Revenue has been growing by 3.03% on average per year.

EPS 1Y (TTM)16.24%

EPS 3Y-0.72%

EPS 5Y3.68%

EPS Q2Q%0%

Revenue 1Y (TTM)-4.11%

Revenue growth 3Y-2.14%

Revenue growth 5Y3.03%

Sales Q2Q%-5.95%

3.2 Future

Based on estimates for the next years, CENTA will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.34% on average per year.
CENTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.37% yearly.

EPS Next Y6.65%

EPS Next 2Y5.96%

EPS Next 3Y6.04%

EPS Next 5Y8.34%

Revenue Next Year0.28%

Revenue Next 2Y1.16%

Revenue Next 3Y2.17%

Revenue Next 5Y3.37%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks Show best growing peers

4. CENTA Valuation Analysis

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.94, the valuation of CENTA can be described as very reasonable.
91.67% of the companies in the same industry are more expensive than CENTA, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 24.88. CENTA is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 10.64, the valuation of CENTA can be described as reasonable.
Based on the Price/Forward Earnings ratio, CENTA is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
CENTA is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	11.94
Fwd PE	10.64

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CENTA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CENTA indicates a rather cheap valuation: CENTA is cheaper than 91.67% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	7.1
EV/EBITDA	7.46

4.3 Compensation for Growth

CENTA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.

PEG (NY)1.8

PEG (5Y)3.24

EPS Next 2Y5.96%

EPS Next 3Y6.04%

More info and screens

Price/Earnings Price/FCF FCF per share EV/EBITDA PEG RATIO Show best valued peers

5. CENTA Dividend Analysis

5.1 Amount

CENTA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks Show peers with best dividend

CENTA Fundamentals: All Metrics, Ratios and Statistics

CENTRAL GARDEN AND PET CO-A

NASDAQ:CENTA (3/27/2026, 8:05:43 PM)

After market: 32.49 0 (0%)

32.49

-0.37 (-1.13%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupHousehold & Personal Products

GICS IndustryHousehold Products

Earnings (Last)02-04 2026-02-04/amc

Earnings (Next)05-05 2026-05-05

Inst Owners97.02%

Inst Owner Change-2.92%

Ins Owners15.97%

Ins Owner ChangeN/A

Market Cap2.02B

Revenue(TTM)3.09B

Net Income(TTM)155.68M

Analysts80

Price Target43.48 (33.83%)

Short Float %10.48%

Short Ratio3.3

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)51.97%

Min EPS beat(2)49.19%

Max EPS beat(2)54.75%

EPS beat(4)4

Avg EPS beat(4)30.19%

Min EPS beat(4)7.2%

Max EPS beat(4)54.75%

EPS beat(8)8

Avg EPS beat(8)289.75%

EPS beat(12)10

Avg EPS beat(12)200.42%

EPS beat(16)13

Avg EPS beat(16)104.47%

Revenue beat(2)1

Avg Revenue beat(2)-1.21%

Min Revenue beat(2)-3.57%

Max Revenue beat(2)1.15%

Revenue beat(4)1

Avg Revenue beat(4)-3.63%

Min Revenue beat(4)-7.03%

Max Revenue beat(4)1.15%

Revenue beat(8)2

Avg Revenue beat(8)-2.8%

Revenue beat(12)4

Avg Revenue beat(12)-2.09%

Revenue beat(16)5

Avg Revenue beat(16)-1.86%

PT rev (1m)-2.2%

PT rev (3m)9.23%

EPS NQ rev (1m)0.73%

EPS NQ rev (3m)0.12%

EPS NY rev (1m)2.3%

EPS NY rev (3m)2.06%

Revenue NQ rev (1m)-0.08%

Revenue NQ rev (3m)-0.23%

Revenue NY rev (1m)-0.22%

Revenue NY rev (3m)-0.56%

Valuation

		Industry Rank	Sector Rank
PE	11.94
Fwd PE	10.64
P/S	0.65
P/FCF	7.1
P/OCF	6.11
P/B	1.28
P/tB	3.49
EV/EBITDA	7.46

EPS(TTM)2.72

EY8.37%

EPS(NY)3.05

Fwd EY9.4%

FCF(TTM)4.58

FCFY14.09%

OCF(TTM)5.32

OCFY16.37%

SpS49.62

BVpS25.3

TBVpS9.31

PEG (NY)1.8

PEG (5Y)3.24

Graham Number39.35

Profitability

		Industry Rank	Sector Rank
ROA	4.27%
ROE	9.88%
ROCE	8.26%
ROIC	6.3%
ROICexc	8.23%
ROICexgc	14.29%
OM	8.21%
PM (TTM)	5.04%
GM	32.29%
FCFM	9.22%

ROA(3y)3.75%

ROA(5y)4.15%

ROE(3y)8.63%

ROE(5y)9.94%

ROIC(3y)6.05%

ROIC(5y)6.55%

ROICexc(3y)7.94%

ROICexc(5y)8.07%

ROICexgc(3y)14.31%

ROICexgc(5y)13.5%

ROCE(3y)7.94%

ROCE(5y)8.59%

ROICexgc growth 3Y9.66%

ROICexgc growth 5Y-1.69%

ROICexc growth 3Y6.99%

ROICexc growth 5Y-5.35%

OM growth 3Y2.97%

OM growth 5Y2.97%

PM growth 3Y4.51%

PM growth 5Y3.05%

GM growth 3Y2.55%

GM growth 5Y1.64%

F-Score7

Asset Turnover0.85

Health

		Industry Rank	Sector Rank
Debt/Equity	0.76
Debt/FCF	4.18
Debt/EBITDA	3.54
Cap/Depr	55.17%
Cap/Sales	1.49%
Interest Coverage	4.39
Cash Conversion	98.19%
Profit Quality	183.07%
Current Ratio	3.42
Quick Ratio	1.97
Altman-Z	2.52

F-Score7

WACC7.07%

ROIC/WACC0.89

Cap/Depr(3y)52.62%

Cap/Depr(5y)81.55%

Cap/Sales(3y)1.43%

Cap/Sales(5y)2.04%

Profit Quality(3y)255.11%

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)16.24%

EPS 3Y-0.72%

EPS 5Y3.68%

EPS Q2Q%0%

EPS Next Y6.65%

EPS Next 2Y5.96%

EPS Next 3Y6.04%

EPS Next 5Y8.34%

Revenue 1Y (TTM)-4.11%

Revenue growth 3Y-2.14%

Revenue growth 5Y3.03%

Sales Q2Q%-5.95%

Revenue Next Year0.28%

Revenue Next 2Y1.16%

Revenue Next 3Y2.17%

Revenue Next 5Y3.37%

EBIT growth 1Y14.56%

EBIT growth 3Y0.77%

EBIT growth 5Y6.09%

EBIT Next Year43.95%

EBIT Next 3Y9.49%

EBIT Next 5YN/A

FCF growth 1Y-13.31%

FCF growth 3YN/A

FCF growth 5Y5.64%

OCF growth 1Y-11.74%

OCF growth 3YN/A

OCF growth 5Y4.7%

CENTRAL GARDEN AND PET CO-A / CENTA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CENTRAL GARDEN AND PET CO-A?

ChartMill assigns a fundamental rating of 4 / 10 to CENTA.

What is the valuation status of CENTRAL GARDEN AND PET CO-A (CENTA) stock?

ChartMill assigns a valuation rating of 7 / 10 to CENTRAL GARDEN AND PET CO-A (CENTA). This can be considered as Undervalued.

How profitable is CENTRAL GARDEN AND PET CO-A (CENTA) stock?

CENTRAL GARDEN AND PET CO-A (CENTA) has a profitability rating of 4 / 10.

How financially healthy is CENTRAL GARDEN AND PET CO-A?

The financial health rating of CENTRAL GARDEN AND PET CO-A (CENTA) is 5 / 10.